FSSAI’s ORS stance should caution GLP-1 nutrition brands
From a regulatory standpoint, nutraceuticals currently exist in the twilight zone, between foods and medicines. And this grey zone has benefitted some brands. In India,...
Home » Editor's Note
Category : Editor’s Note
Pharma, FMCG majors look for a nutra fix
We mark Express Nutra’s first anniversary with promising deal activity in the nutraceutical sector. As expected, the deals continue the trend of pharma companies morphing...
Nutra honchos urge policy clarity, support in budget
India’s nutra sector’s pre budget recommendations hint at the angst of being a nascent sector, competing for fiscal support with more established big brother siblings...
Getting nutra GMP right before it’s too late
India’s nutraceutical players hope to make it big as nutra CDMOs, replicating its success as a global pharma CDMO force to reckon with. But India’s...
Marrying the ancient with the modern
Companies in this space will need to back their claims with clinical evidence to satisfy regulators and consumers...
Show us the data
Another disconnect between the regulators and most nutra players is the need for rigorous scientific validation and transparency in product claims. Most clinicians too emphasise...
Express Nutra to surf the sangam of science and wellness trends
Be it wellness supplements to critical onco-nutritional formulations, market trends and business strategies, regulatory updates, leadership insights, and showcasing technology and innovation, Express Nutra aims...